| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10817300 | Clinica Chimica Acta | 2005 | 6 Pages |
Abstract
We conclude that down-regulation of the KLK11 gene in advanced and more aggressive tumors may open the possibility of being used as a future biological marker distinguishing the tumor aggressiveness as well as a useful prognostic biomarker for prostate cancer.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Panagiota Stavropoulou, Alkiviades K. Gregorakis, Mario Plebani, Andreas Scorilas,